文献速递血管炎

系统性坏死性血管炎患者严重感染预测因素:法国血管炎研究组五项随机对照试验733例患者数据

Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

该研究汇总法国血管炎研究组五项随机对照试验共733例系统性坏死性血管炎患者数据,中位随访5.2年,148例(20.2%)发生189次严重感染,98例(66.2%)首次严重感染发生在头2年内。年龄≥65岁、肺部受累和五因子评分≥1是严重感染的独立预测因素,严重感染显著负向影响生存。

要点

  • 年龄≥65岁、肺部受累和五因子评分≥1是严重感染的独立预测因素。
  • 糖皮质激素联合环磷酰胺诱导治疗与严重感染发生相关。
  • 严重感染显著负向影响生存。

核心结论

  • 系统性坏死性血管炎中严重感染常见且影响死亡率。
  • 年龄、肺部受累和五因子评分是严重感染的基线独立预测因素。
  • 未发现治疗方案与严重感染显著相关,但糖皮质激素联合环磷酰胺诱导治疗的患者倾向于发生更多严重感染。

研究设计与样本

  • 汇总法国血管炎研究组五项随机对照试验数据,共纳入733例系统性坏死性血管炎患者。
  • 主要终点为严重感染,定义为需要住院和/或静脉抗感染治疗和/或导致死亡。
  • 中位随访5.2年(四分位距3-9.7年)。

主要发现

  • 148例(20.2%)患者发生189次严重感染,98例(66.2%)首次严重感染发生在头2年内。
  • 从入组到严重感染的中位间隔为14.9个月(4.3-51.7个月)。
  • 严重感染的发生对生存有显著负向影响(P<0.001)。

关键数值与推荐

  • 严重感染定义:需要住院和/或静脉抗感染治疗和/或导致死亡。

临床怎么用

  • 对年龄≥65岁、肺部受累或五因子评分≥1的系统性坏死性血管炎患者,应加强严重感染的监测与预防。
  • 严重感染多见于头2年内,提示诱导治疗期间需密切警惕感染风险。
  • 糖皮质激素联合环磷酰胺诱导治疗者可能需更积极的感染预防策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Infections remain a major cause of morbidity and mortality in systemic necrotizing vasculitides (SNV). We aimed to identify factors predicting severe infections (SI) in SNV. METHODS: Data from five randomized controlled trials (RCTs) enrolling 733 patients were pooled. The primary end point was the occurrence of SI, defined by the need of a hospitalization and/or intravenous anti-infectious treatment and/or leading to death. RESULTS: After a median follow-up of 5.2 (interquartile range 3-9.7) years, 148 (20.2%) patients experienced 189 SI, and 98 (66.2%) presented their first SI within the first 2 years. Median interval from inclusion to SI was 14.9 (4.3-51.7) months. Age ≥65 years (hazard ratio (HR) 1.49 [1.07-2.07]; P=0.019), pulmonary involvement (HR 1.82 [1.26-2.62]; P=0.001) and Five Factor Score ≥1 (HR 1.21 [1.03-1.43]; P=0.019) were independent predictive factors of SI. Regarding induction therapy, the occurrence of SI was associated with the combination of GCs and CYC (HR 1.51 [1.03-2.22]; P = 0.036), while patients receiving only GCs were less likely to present SI (HR 0.69 [0.44-1.07]; P = 0.096). Finally, occurrence of SI had a significant negative impact on survival (P<0.001). CONCLUSION: SI in SNV are frequent and impact mortality. Age, pulmonary involvement and Five Factor Score are baseline independent predictors of SI. No therapeutic regimen was significantly associated with SI but patients receiving glucocorticoids and CYC as induction tended to have more SI.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Lafarge A, Joseph A, Pagnoux C, et al. Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group. Rheumatology (Oxford). 2020. PMID: 31782786. doi:10.1093/rheumatology/kez575

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。